- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02521194
Occupational Therapy in Palliative Care
Is Inpatient Occupational Therapy Perceived to be Beneficial by the Palliative Patient and Caregiver?
Studieoversikt
Detaljert beskrivelse
Caregivers Consent:
If you agree to take part in this study, you will complete a questionnaire about your opinion on the inpatient occupational therapy session the patient (person you are caring for) received. It should take about 10 minutes to complete the questionnaire. You will be left alone in a room to complete the questionnaire.
Length of Study:
Your participation on this study will be over after you complete the questionnaire.
This is an investigational study.
50 patients and up to 50 caregivers will take part in this study. All will be enrolled at MD Anderson.
Patients Consent:
If you agree to take part in this study, you will complete a questionnaire about your opinion of the inpatient occupational therapy session you just had. The questionnaire should take about 10 minutes to complete. You will be left alone in the room to complete the questionnaire.
Length of Study:
You participation on this study will be over after you complete the questionnaire.
This is an investigational study.
50 patients and up to 50 caregivers will take part in this study. All will be enrolled at MD Anderson.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- University of Texas MD Anderson Cancer Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients must have an inpatient occupational therapy (OT) order and be able to tolerate an OT session as judged by the attending physician
- Patients with cancer admitted to inpatient acute palliative care unit
- Caregiver participation is optional, but must be identified as the primary caregiver in order to complete the Caregiver Satisfaction Survey.
- Caregiver (if participating) must be present during the session.
- Patient (and caregiver (if participating) must be 18 years of age or older.
- Both patient (and caregiver if participating) must be able to understand, read, write and speak English.
- Both patient and caregiver (if participating) must sign an Informed Consent Form.
Exclusion Criteria:
- Patients or caregivers with physical limitations (visual or motor impairment) causing inability to read, complete or sign the consent form and survey.
- Patients or caregivers who the attending physician deems unable to participate due to poor cognitive capacity or acute physical distress.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Caregiver Questionnaire
Questionnaire completion regarding opinion on the inpatient occupational therapy session person being cared for received.
|
Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.
Andre navn:
|
|
Eksperimentell: Patient Questionnaire
Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.
|
Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Satisfaction Rate of Inpatient Occupational Therapy Session
Tidsramme: 1 day
|
Satisfaction rate defined as the percentage of patients that "strongly agree" or "agree" after inpatient occupational session as being beneficial.
|
1 day
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Paul W. Walker, MD, M.D. Anderson Cancer Center
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 2015-0350
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .